Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study

Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study

BackgroundThe potential link between disease-modifying therapies (DMTs) and malignancy in multiple sclerosis (MS) patients has generated significant concern, particularly given the immunosuppressive nature of these treatments. Conflicting evidence in the literature has left this issue unresolved, un...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Bayounis, Mohammed Bin Mahfooz, Mohammed Assiri, Yousef Alghamdi, Fahad Alturki, Mahdi Almutairi, Abdullah Alshelawy, Mohammed Alosaimi, Faisal Almutawa, Abdulrahman Alammar, Yahya Alyahya, Osama Khojah, Seraj Makkawi, Yaser Al Malik
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Neurology
Subjects:
multiple scleorsis
neuroimmunology
malignancy
disease modifying therapies
DMT
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1492678/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1492678/full

Similar Items